ABK Biomedical and MURR forge long-term partnership to advance breakthrough cancer therapy
A new agreement names MURR as the primary irradiation partner for ABK Biomedical's Eye90 microspheres.
DOE and MURR secure critical radioisotope supply chain for medical imaging
The University of Missouri Research Reactor is now the only domestic supplier of gadolinium-153 through a new agreement with the Department of Energy.
NextGen MURR teams with Burns & McDonnell, supporting the future of lifesaving nuclear medical isotope production
The drive to build a new state-of-the-art research reactor at Mizzou continues as a major milestone is reached.
MURR makes NCA Lu-177 available worldwide
Expanded supply will enable researchers and industry to purchase GMP no-carrier-added Lutetium-177 directly from the reactor.
University of Missouri conducts first in-person clinical trial for nuclear medicine breakthrough device
The clinical trial marks the latest human trial at Mizzou involving radioisotopes to treat cancer.
University of Missouri opens addition to MU Research Reactor facility
The $20 million, three-story addition to the existing MURR North Building offers new opportunities for industry collaboration and advances in nuclear science.